VITEKÂ® MS CE-Marked Database Expands to Include Mycobacteria, Nocardia and Moulds
bioMĂ©rieux haveÂ launched the first CE-marked database and reagent kits for the identification of mycobacteria,Â NocardiaÂ and moulds in a MALDI-TOFÂ Mass Spectrometry System. This innovative solution further enhances the VITEKÂ®Â MS systemâ€™s performance by adding 297 new species including identification of theÂ Mycobacterium tuberculosisÂ (TB) group, 45 species of the most frequent non-tuberculous mycobacteria (NTM), and 48 of the most medically important moulds. TheÂ VITEKÂ®Â MS systemâ€™s new database and the reagents kits are now commercially available in countries which recognize CE-marking.
Mycobacteria,Â NocardiaÂ and moulds are difficult to identify organisms, requiring days or weeks of specific culture conditions for appropriate growth and subsequent advanced methods for reliable identification to species level. The updated VITEKÂ®Â MS system, however, can now offer simple, rapid and reliable identification of these pathogens, providing clinicians with actionable results to manage the infections which they cause, such as tuberculosis, lung and bone infections, and other serious organ infections.
Based on patented methods, the VITEKÂ®Â MS Mycobacterium/NocardiaÂ and Mould reagent kits enable easy, rapid, and safe identification of these organisms. The VITEKÂ®Â Â MS extended database now enables the identification within minutes of 1,046Â species representing 15,172 distinct strains of bacteria, yeasts and moulds. The convenient, user-friendly reagent kits for use with this highly automated mass spectrometry system provide lab professionals with extremely reliable results.
For microbiologists who choose mass spectrometry for microbial identification, bioMĂ©rieux offers a fully integrated solution combining identification with VITEKÂ®Â MS and antibiotic susceptibility testing with VITEKÂ®Â 2, resulting in enhanced pathogen information, and superior workflow management.
Date Published: 12th July 2016
Source article link: bioMĂ©rieux (Clinical Diagnostics)